Posts by Sandra Ansanay-Alex
Dr. Andrea Pfeifer received the Aenne Burda Award
The CEO and Director of AC Immune SA was recognized for her work to find treatments for Alzheimer’s disease AC Immune SA (NASDAQ: ACIU), a Lausanne-based clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, announced that Dr. Andrea Pfeifer, CEO and a Director of AC Immune, was awarded the prestigious Aenne Burda Award…
Read MoreKodiak Sciences and Lonza open a new facility in Visp
Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat retinal diseases, and Lonza announced on 17 May 2022 the opening of a new, custom-built, bioconjugation facility within Lonza’s Ibex® Dedicate manufacturing complex in Visp, Switzerland. The facility will play a key role in the scaled…
Read MoreSpArk, the centre for movement science and technologies, is born!
This new centre, dedicated to sport and performance, is the result of collaboration between the City of Sion and The Ark Foundation. Officially launched on Thursday 19 May, SpArk aims to exploit the potential of digitalisation in health, sport and performance. The new cluster aims to be a driving force for economic development, by…
Read MoreHansjörg Wyss, the life sciences philanthropist
On 17 May 2022, Hansjörg Wyss received the Gallatin Award from the Swiss American Chamber of Commerce for his great commitment to the science landscape in Switzerland. “The ongoing commitment of Hansjörg Wyss and his Foundation to support groundbreaking research in Switzerland and elsewhere is more than a gift: it is a strong symbol…
Read MoreONWARD’s Neurostimulator Restores Mobility for Patients with Spinal Cord Injury
This is the first time the ARCIM is used on a human patient. This implantable pulse generator (IPG) stimulates the spinal cord to restore movement and autonomic functions for people with spinal cord injury and other conditions that affect mobility. This first implant on a human patient is a major milestone in ONWARD’s successful…
Read MoreHemostOD creates ex vivo blood platelets
HemostOD has developed a solution for ex vivo on-demand production of blood platelets. The company just received a CHF 100 000 Tech Seed loan from the Foundation for Technological Innovation (FIT). Worldwide, 10 million platelet concentrates are transfused each year. Platelets are small blood cells whose function is to stop bleeding. Today, patients can only…
Read MoreSwiss biotech companies attracted investments of $3.33 billion in 2021
Last year was ‘the second best year in terms of fundraising’, according to the Swiss Biotech Association. The sector benefited from a “still strong” international contribution. Of the $3.33 billion, $2.51 billion was invested in listed companies, including Sophia Genetics in Lausanne, with $234 million following its initial public offering (IPO) and its follow-up,…
Read MoreSwiss Medtech Day
The Swiss Medtech Day is taking place on 9 June 2027 in Kursaal, Bern. The overarching theme for 2024-2026 is Mastering Complexity. This theme addresses the dynamic changes in the world and the challenges faced by the medical technology industry. The Swiss Medtech Day provides a platform for discussing these challenges. By sharing experiences, best…
Read MorePodcast: Claude Clément
BioAlps President, Claude Clément, discusses career choices and how to lead innovation in the healthcare industry in the podcast What To Do Next? Claude Clément first worked in R&D for the watch industry (Swatch Group🇨🇭), then entered the world of medical technologies by heading the diversification activities of Swatch in the field of wearable programmable drug delivery…
Read MoreMerck Serono improves quality control with IA
Artificial Intelligence helps to assess the severity of a manufacturing incident in a medicine production unit In any factory, every day, a problem occurs. But when it happens at a site that manufactures cancer or multiple sclerosis drugs, the consequences can turn into a catastrophe. In order to make the right decisions as quickly…
Read More